Search Results

Refine

Result Type

1 - 6 of 6 Products for 'John Ambroseo Phd' Page 1 of 1 |
  • 1

John Ambroseo Phd

34706a cover.indd

34706a cover.indd

…Chief Executive Officer and each of our other
executive officers as of December 31, 2016 are set forth below:
Name Age Office Held
John R. Ambroseo(1) President and Chief Executive Officer
Kevin Palatnik(1) Executive Vice President and Chief Financial Officer
Mark Sobey(1)…

Coherent

Coherent

…Executive Officer, and a member of the Board of Directors of
Molecular Dynamics, Inc., a Nasdaq-listed life sciences company
John R. Ambroseo. Mr. Ambroseo has served as our President and Chief
focused on genetic discovery and analysis, from 1994 until its sale to
Executive…

an rep 2018 workfile 02

an rep 2018 workfile 02

…COHERENT, INC.
Garry W. Rogerson, Ph.D.
Chairman of the Board, Coherent, Inc.
Former Chief Executive Officer,
Advanced Energy Industries, Inc.
Jay T. Flatley
Executive Chairman
Illumina, Inc.
John R. Ambroseo, Ph.D.
President and Chief Executive Officer…

Coherent Appoints Andy Mattes as new CEO.pdf?v=20-20-04 06-11-48

Coherent Appoints Andy Mattes as new CEO.pdf?v=20-20-04 06-11-48

…immediately. Today's appointment follows the announcement a year ago that John R. Ambroseo, PhD will retire from his positions as President and Chief Executive Officer and member of the Board no later than April 2021. John Ambroseo will transition to become a Special Advisor to the company until the…

Coherent Appoints Andy Mattes as new CEO.pdf

Coherent Appoints Andy Mattes as new CEO.pdf

…immediately. Today's appointment follows the announcement a year ago that John R. Ambroseo, PhD will retire from his positions as President and Chief Executive Officer and member of the Board no later than April 2021. John Ambroseo will transition to become a Special Advisor to the company until the…

32311a coverSinglesRR.indd

32311a coverSinglesRR.indd

…Executive Officer, and a member of the Board of Directors of
Molecular Dynamics, Inc., a Nasdaq-listed life sciences company
John R. Ambroseo. Mr. Ambroseo has served as our President and Chief
focused on genetic discovery and analysis, from 1994 until its sale to
Executive…